Olaparib is an FDA-approved targeted therapy for cancer. It is a PARP inhibitor, inhibiting poly ADP ribose polymerase, an enzyme involved in DNA repair. It acts against cancers in people with hereditary BRCA1 or BRCA2 mutations, which include some ovarian, breast, and prostate cancers.
![]() |
GOOD FAITH PHARMA IMPEX
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |